# iBio (IBIO) — Earnings

IBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ibio/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.32 |
| EPS estimate | −$0.35 |
| EPS surprise | +8.57% |
| Revenue surprise | +100.00% |
| Revenue | $200,000.00 |
| Revenue estimate | $100,000.00 |
| Reported | Sep 5, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1420720/000155837025011885/ibio-20250905x8k.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2025 | Sep 5, 2025 | −$0.35 | −$0.32 | 8.57% | $100,000.00 | $200,000.00 |
| Q3 2025 | May 2, 2025 | −$0.32 | −$0.49 | -53.13% | $100,000.00 | — |
| Q2 2025 | Feb 10, 2025 | −$0.46 | −$0.48 | -4.35% | — | $200,000.00 |
| Q1 2025 | Nov 12, 2024 | −$0.46 | −$0.46 | 0.00% | — | — |
| Q4 2024 | Sep 20, 2024 | −$0.47 | −$0.38 | 19.15% | — | $175,000.00 |
| Q3 2024 | May 13, 2024 | $0.00 | −$0.71 | 0.00% | — | — |
| Q2 2023 | Feb 14, 2023 | −$146.90 | −$68.40 | 53.44% | $600,000.00 | — |
| Q4 2022 | Oct 11, 2022 | −$32.50 | −$41.90 | -28.92% | $250,000.00 | $100,000.00 |
| Q3 2022 | May 12, 2022 | −$27.50 | −$30.00 | -9.09% | $200,000.00 | $1.9M |
| Q2 2022 | Feb 14, 2022 | −$20.00 | −$25.00 | -25.00% | $250,000.00 | $168,000.00 |
| Q1 2022 | Nov 15, 2021 | −$25.00 | −$20.00 | 20.00% | $500,000.00 | $211,000.00 |
| Q4 2021 | Sep 27, 2021 | −$20.00 | $5.00 | 125.00% | $800,000.00 | $500,000.00 |
| Q3 2021 | May 17, 2021 | −$20.00 | −$20.00 | 0.00% | $800,000.00 | $765,000.00 |
| Q2 2021 | Feb 16, 2021 | −$17.50 | −$20.00 | -14.29% | $650,000.00 | $705,000.00 |
| Q1 2021 | Nov 16, 2020 | −$40.00 | −$25.00 | 37.50% | $100,000.00 | $410,000.00 |
| Q4 2020 | Oct 13, 2020 | −$25.00 | −$15.00 | 40.00% | $100,000.00 | $1.1M |

## Frequently Asked Questions

### When did iBio (IBIO) last report earnings?

iBio last reported on Sep 5, 2025, covering fiscal Q4 2025.

### Did IBIO beat earnings estimates?

Yes. iBio reported EPS of −$0.32 for Q4 2025 against a −$0.35 estimate — a 8.57% beat.

### How much revenue did IBIO report last quarter?

iBio reported $200,000.00 in revenue for Q4 2025, against a consensus estimate of $100,000.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).